Thrombosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

New Data Proves Role of Thrombosis in Patients with MPNs - Rare Disease Report



Rare Disease Report
 
New Data Proves Role of Thrombosis in Patients with MPNs 
Rare Disease Report
Malin Hultcrantz, M.D., PhD and colleagues, in an effort to address the gap in knowledge, evaluated data from 9,429 patients ? 46% of whom were male ? diagnosed with MPNs who reported to the Swedish Cancer Register between 1987 and 2009, and matched ...

 


'Eye-opening' Study on Rates of Thrombosis With MPNs - Medscape



Medscape
 
'Eye-opening' Study on Rates of Thrombosis With MPNs 
Medscape
"Patients with MPNs across all age groups have a significantly increased rate of arterial and venous thrombosis compared to matched controls," conclude the authors, led by Malin Hultcrantz, MD, PhD, from the Karolinska Institute in Stockholm and the ...

 


MPN Patients See Increased Rate of Arterial, Venous Thrombosis - MedPage Today



Medical Xpress
 
MPN Patients See Increased Rate of Arterial, Venous Thrombosis 
MedPage Today
Patients with myeloproliferative neoplasms (MPNs) across all age groups had a significantly increased risk of arterial and venous thrombosis compared with matched control participants, with the highest risk shortly after MPN diagnosis, a Swedish ...
Thrombosis Risk Examined in Myeloproliferative Neoplasms Monthly Prescribing Reference
Increased risk of thrombosis in myeloproliferative neoplasms Medical Xpress

all 2 news articles » 


Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera 
Oncology Nurse Advisor
Patients with PV frequently experience thrombotic complications ? a cause of significant morbidity and mortality in this patient population ? yet risk factors predicting venous and arterial thrombosis have not been fully elucidated. For this study ...

 


Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms - Annals of Internal Medicine



Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms 
Annals of Internal Medicine
The HRs for arterial thrombosis among patients with MPNs compared with control participants at 3 months, 1 year, and 5 years were 3.0 (95% CI, 2.7 to 3.4), 2.0 (CI, 1.8 to 2.2), and 1.5 (CI, 1.4 to 1.6), respectively. The corresponding HRs for venous ...
Myeloproliferative neoplasms significantly increase thrombotic risk Healio
Patients with myeloproliferative neoplasms have a significantly increased risk for arterial and venous thrombosis Brinkwire (press release)

all 5 news articles » 


Deep Vein Thrombosis (DVT) Drug Market: Industry Analysis ... - GEOPOLMonitor



Deep Vein Thrombosis (DVT) Drug Market: Industry Analysis ... 
GEOPOLMonitor
Deep Vein Thrombosis (DVT) Drug Market Research Report is a professional and in-depth study on the current state of the Deep Vein Thrombosis (DVT) Drug industry. The report provides a basic overview of the industry including definitions ...

and more » 


Global Cardiovascular Disease Drugs Market 2017-2023 - Expiries ... - Business Wire (press release)



Global Cardiovascular Disease Drugs Market 2017-2023 - Expiries ... 
Business Wire (press release)
Global Cardiovascular Disease Drugs Market to 2023 provides an introduction to cardiovascular disease (CVD), including disease symptoms, diagnosis, etiology, pathophysiology, comorbidities and complications, epidemiology, prognosis and treatment. CVD ...

and more » 


ISTH educational course "All you should know about thrombosis" to take place on 19 January in Yerevan - Information-Analytic Agency NEWS.am



Information-Analytic Agency NEWS.am
 
ISTH educational course "All you should know about thrombosis" to take place on 19 January in Yerevan 
Information-Analytic Agency NEWS.am
ISTH educational course "All you should know about thrombosis" will start in Medical State University (Yerevan, Armenia) on 19 January, at 09:15. Famous doctors from Armenia and other countries will take part in the course. Among the lecturers are ...

 


Could Aspirin Sub for Heparin to Prevent Cancer-Associated Thrombosis? - MedPage Today



Could Aspirin Sub for Heparin to Prevent Cancer-Associated Thrombosis? 
MedPage Today
"Larger blinded clinical trials to determine the optimal antithrombotic strategy for these high-risk patients appear feasible and safe," they suggested. "Comparing aspirin with direct oral anticoagulants instead of injectable heparins should be ...

 


New study validates clotting risk factors in chronic kidney disease - Medical Xpress



Medical Xpress
 
New study validates clotting risk factors in chronic kidney disease 
Medical Xpress
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) patients from developing ...